4SC to Present at Two Upcoming Investor Conferences
News Apr 17, 2012
4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, will be presenting at two investor conferences this week.
Dr Ulrich Dauer, Chief Executive Officer of 4SC AG, will give a company presentation at the Future Leaders in the Biotech Industry conference, which will be held on 20 April 2012 in New York City, USA.
The presentation of 4SC will begin at 9.00am (ET).
Enno Spillner, Chief Financial Officer of 4SC AG, will give a company presentation at the 3rd FCF Family-to-Family Day, an investor conference exclusively for family offices and HNIs (High Net Worth Individuals) on 19 April 2012 in Munich.
The presentation of 4SC will begin at 3.15pm (CET).
RELATED ARTICLES
Chemists Teach Enzyme New Tricks
NewsPrinceton chemists have found a way to make a naturally occurring enzyme take on a new, artificial role, which has significant implications for modern chemistry, including pharmaceutical production.
READ MORE
Research Team Discovers Compound that Stops Cancer From Spreading
NewsUsing a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.
READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs
NewsPhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.
READ MOREComments | 0 ADD COMMENT
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
Login
You must be logged in to post a comment.